HONG KONG, June 12, 2017 /PRNewswire/ -- On June 13, 2017 Hong Kong time, WuXi Biologics (Cayman) Inc. ("the Company"; stock code: 2269.HK) was officially listed during a grand listing ceremony at the Main Board of The Stock Exchange
Headquartered in Wuxi city, Jiangsu province, with three operation sites in Wuxi, Shanghai and Suzhou respectively, WuXi Biologics is the only open-access biologics capability and technology enabling platform in the world with end-to-end solutions, empowering anyone and any company to discover, develop and manufacture biologics from concept to commercial manufacturing.
"The successful listing of WuXi Biologics on the Hong Kong Stock Exchange marks another important milestone in the history of the Company," said Dr. Ge Li. "This will further accelerate our expansion in capabilities and capacities, strengthen our leadership position as the most comprehensive and integrated enabling platform, and will allow us to better enable innovation to benefit patients worldwide."
"The successful listing on the Main Board of the Stock Exchange of Hong Kong is a new starting point for WuXi Biologics," said Dr. Chris Chen. "We will further standardize the operation and management of the Company, strictly abide by the Listing Rules, and diligently fulfill various regulatory obligations as a public company. We will reciprocate the trust of our collaborative partners, investors, and employees with strong performance, sustainable growth, and value for patients and society."
About WuXi Biologics
WuXi Biologics, a WuXi AppTec Affiliate, is a leading open-access technology capability and technology platform to enable anyone and any company to develop biologics. WuXi Biologics provides our worldwide clients with the necessary expertise, quality and capacities to develop biologic drugs from concept to commercialization. Along with our WuXi AppTec affiliates, we provide the world with the ONE true single-source approach that saves our clients critical time and money. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and value proposition to our global clients. For more information on WuXi's Biologics services, please visit: http://www.wuxibiologics.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wuxi-biologics-is-officially-listed-on-the-hong-kong-stock-exchange-300472744.html
SOURCE WuXi Biologics
Subscribe to our Free Newsletters!
Immunotherapy is a type of treatment method that works by using certain components of a person's ...
Increasing weight and obesity are some of the most common health problems today. A smart weight ...View All